Rafferty Asset Management
AZN icon

Rafferty Asset Management’s AstraZeneca AZN Stock Holding History

Rafferty Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67,132
Closed -$12.3M – 1070
2025
Q4 		$12.3M Sell
67,132
-13,117
-16% -$2.3M 0.04% 234
2025
Q3 		$12.3M Sell
80,249
-3,946
-5% -$597K 0.04% 241
2025
Q2 		$11.8M Sell
84,195
-541
-0.6% -$75.8K 0.04% 247
2025
Q1 		$12.5M Sell
84,736
-13,593
-14% -$1.97M 0.05% 218
2024
Q4 		$12.9M Buy
98,329
+23,459
+31% +$3.28M 0.05% 238
2024
Q3 		$11.7M Sell
74,870
-3,883
-5% -$627K 0.04% 261
2024
Q2 		$12.3M Sell
78,753
-15,155
-16% -$2.28M 0.05% 252
2024
Q1 		$12.7M Buy
93,908
+10,428
+12% +$1.38M 0.05% 221
2023
Q4 		$11.2M Buy
83,480
+21,732
+35% +$2.83M 0.05% 240
2023
Q3 		$8.36M Buy
61,748
+14,292
+30% +$1.95M 0.05% 271
2023
Q2 		$6.79M Buy
47,456
+7,750
+20% +$1.14M 0.04% 350
2023
Q1 		$5.51M Buy
39,706
+6,961
+21% +$937K 0.04% 365
2022
Q4 		$4.44M Sell
32,745
-25,220
-44% -$3.16M 0.04% 399
2022
Q3 		$6.36M Buy
57,965
+5,136
+10% +$652K 0.07% 268
2022
Q2 		$6.98M Buy
52,829
+553
+1% +$72.6K 0.06% 217
2022
Q1 		$6.94M Buy
+52,276
New +$6.27M 0.04% 271

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Rafferty Asset Management's AZN Position: Q1 2026 in Review

Rafferty Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 67,132 shares — an estimated $12.3M sold.

Rafferty Asset Management first reported a position in AZN in Q1 2022 and held it in 16 quarters. The position peaked at $12.9M in Q4 2024. 1,386 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Rafferty Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 67,132 AstraZeneca shares in Q1 2026, an estimated $12.3M.
  • Rafferty Asset Management first reported a position in AstraZeneca in Q1 2022 and held it in 16 quarters.
  • Rafferty Asset Management's AstraZeneca position peaked at $12.9M in Q4 2024.
  • 1,386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.